The role of heparins and nano-heparins as therapeutic tool in breast cancer (Q38806104)

6 September 2017

1 reference

title

The role of heparins and nano-heparins as therapeutic tool in breast cancer (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Zoi Piperigkou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Konstantina Karamanou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Demitrios H Vynios

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Achilleas D Theocharis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

24 October 2016

1 reference

6 September 2017

published in

Glycoconjugate Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

299-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

Glycosaminoglycans: key players in cancer cell biology and treatment

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparan sulfate: biological significance, tools for biochemical analysis and structural characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Determination of twelve heparin- and heparan sulfate-derived disaccharides as 2-aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser-induced fluorescence detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Serglycin: at the crossroad of inflammation and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Serglycin is essential for maturation of mast cell secretory granule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Pharmacology of Heparin and Related Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

The heparins: all a nephrologist should know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparin-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Extracellular matrix structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains: NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparan sulfate mediates trastuzumab effect in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

NFAT promotes carcinoma invasive migration through glypican-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Glypican-3 expression is silenced in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Effect of sulfated glycosaminoglycans on tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Mechanisms of heparin induced anti-cancer activity in experimental cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Sulfated Hexasaccharides Attenuate Metastasis by Inhibition of P-selectin and Heparanase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Glycosaminoglycans in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Advanced nanocarriers based on heparin and its derivatives for cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Physico-chemical features of engineered nanoparticles relevant to their toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Biodegradable polylactic acid polymer with nisin for use in antimicrobial food packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Immunological properties of engineered nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9742-7

Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells

21 January 2018

1 reference

12 December 2020

Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate

1 reference

12 December 2020

Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype

1 reference

12 December 2020

Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules

1 reference

12 December 2020

Heparin based nanoparticles for cancer targeting and noninvasive imaging

1 reference

12 December 2020

M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis

1 reference

12 December 2020

Protein bio-corona: critical issue in immune nanotoxicology

1 reference

12 December 2020

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine

1 reference

12 December 2020

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

1 reference

12 December 2020

Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.

1 reference

12 December 2020

10.1007/S10719-016-9742-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27778131%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 June 2020

1008301534

0 references

Fatcat ID

release_n42eqpc7hjgitgr4zn43mb2vme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n42eqpc7hjgitgr4zn43mb2vme

24 November 2022

mapped directly with Wikidata item

1 reference